Key result
Normal DSE does not guarantee a benign long-term prognosis, as risk depends on specific patient characteristics.
Why the study?
What are the long-term outcomes and predictors of adverse events in patients with a normal dobutamine stress echocardiogram?
Cohort (n=3,014)
What are the long-term outcomes and predictors of adverse events in patients with a normal dobutamine stress echocardiogram?
A normal dobutamine stress echocardiogram does not guarantee a benign long-term prognosis, as risk is modulated by age, diabetes, and chronotropic incompetence.
Answers are grounded in this paper and cite their sources.
Supports careful clinical evaluation after normal dobutamine stress echocardiography; leaves open whether risk-based interventions improve long-term outcomes.
AIMS: Normal exercise echocardiography predicts a good prognosis. Dobutamine stress echocardiography (DSE) is generally reserved for patients with comorbidities which preclude exercise testing. We evaluated predictors of adverse events after normal DSE. METHODS AND RESULTS: We studied 3014 patients (1200 males, 68+/-12 years) with normal DSE, defined as the absence of wall motion abnormality at rest or with stress. During median follow-up of 6.3 years, all-cause mortality and cardiac events, defined as myocardial infarction and coronary revascularization, occurred in 920 (31%) and 231 (7.7%) patients, respectively. Survival and cardiac event-free probabilities were 95 and 98% at 1 year, 78 and 93% at 5 years, and 56 and 89% at 10 years, respectively. Age, diabetes mellitus, and failure to achieve 85% age-predicted maximal heart rate were independent predictors of mortality and cardiac events. Patients with all three of these characteristics had a 13% probability of cardiac events within the first year and higher risk throughout follow-up. CONCLUSION: Prognosis after normal DSE is not necessarily benign, but depends on patient and stress test characteristics. Careful evaluation, using clinical and stress data, is required to identify patients with normal DSE who are at increased risk of adverse outcomes during long-term follow-up.
No takes yet. Share an insight, caveat, or question.
Chaowalit et al. (2006) conducted a cohort in Patients undergoing dobutamine stress echocardiography (n=3,014). Normal dobutamine stress echocardiography was evaluated on All-cause mortality and cardiac events (myocardial infarction and coronary revascularization). After normal dobutamine stress echocardiography, all-cause mortality occurred in 31% and cardiac events in 7.7% over a median 6.3-year follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: